Financials medmix AG

Equities

MEDX

CH1129677105

Medical Equipment, Supplies & Distribution

Market Closed - Swiss Exchange 11:31:30 2024-04-26 am EDT 5-day change 1st Jan Change
15.22 CHF +1.20% Intraday chart for medmix AG +1.06% -19.89%

Valuation

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Capitalization 1 1,863 720.1 776.7 620.7 - -
Enterprise Value (EV) 1 1,974 876.8 776.7 781.1 729.5 685.9
P/E ratio 42.2 x 62.9 x 1,900 x 18.3 x 12.1 x 8.99 x
Yield 1.11% 2.84% - 4.93% 5.42% 7.23%
Capitalization / Revenue 4.07 x 1.51 x 1.6 x 1.19 x 1.1 x 1.03 x
EV / Revenue 4.32 x 1.84 x 1.6 x 1.5 x 1.3 x 1.13 x
EV / EBITDA 17.7 x 12.4 x 10.4 x 6.91 x 5.62 x -
EV / FCF 34.3 x 78.3 x - 15.7 x 17.6 x -
FCF Yield 2.91% 1.28% - 6.35% 5.69% -
Price to Book 3.48 x 1.44 x - 1.29 x 1.17 x 1.16 x
Nbr of stocks (in thousands) 41,262 40,914 40,877 40,782 - -
Reference price 2 45.16 17.60 19.00 15.22 15.22 15.22
Announcement Date 2/22/22 2/21/23 2/22/24 - - -
1CHF in Million2CHF
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Net sales 1 351.3 457.3 477.1 486.6 520.6 563 605
EBITDA 1 - 111.7 70.7 74.4 113.1 129.9 -
EBIT 1 - 59.9 19.6 16 56.59 67.75 -
Operating Margin - 13.1% 4.11% 3.29% 10.87% 12.03% -
Earnings before Tax (EBT) - 51.3 12.2 - - - -
Net income 1 9.6 44 11.6 0.3 34.28 51.78 69.89
Net margin 2.73% 9.62% 2.43% 0.06% 6.59% 9.2% 11.55%
EPS 2 - 1.070 0.2800 0.0100 0.8309 1.258 1.694
Free Cash Flow 1 - 57.5 11.2 - 49.64 41.49 -
FCF margin - 12.57% 2.35% - 9.53% 7.37% -
FCF Conversion (EBITDA) - 51.48% 15.84% - 43.9% 31.94% -
FCF Conversion (Net income) - 130.68% 96.55% - 144.79% 80.14% -
Dividend per Share 2 - 0.5000 0.5000 - 0.7500 0.8250 1.100
Announcement Date 8/16/21 2/22/22 2/21/23 2/22/24 - - -
1CHF in Million2CHF
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 S1 2021 S2 2022 S1 2022 S2 2023 S1
Net sales 1 228.3 229 250.6 226.5 248.1
EBITDA 1 - 54.8 56.5 14.2 40
EBIT 1 - 28.6 31.3 -11.7 14.5
Operating Margin - 12.49% 12.49% -5.17% 5.84%
Earnings before Tax (EBT) - - - - -
Net income 1 22.7 21.3 23.8 -12.2 7.3
Net margin 9.94% 9.3% 9.5% -5.39% 2.94%
EPS 2 - - 0.5800 -0.3000 0.1800
Dividend per Share - - - - -
Announcement Date 11/4/21 2/22/22 7/21/22 2/21/23 7/21/23
1CHF in Million2CHF
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - 111 157 - 160 109 65.2
Net Cash position 1 - - - - - - -
Leverage (Debt/EBITDA) - 0.9928 x 2.216 x - 1.419 x 0.8372 x -
Free Cash Flow 1 - 57.5 11.2 - 49.6 41.5 -
ROE (net income / shareholders' equity) - 10.7% 8.59% - 7.13% 11.3% 13.2%
ROA (Net income/ Total Assets) - - - - - - -
Assets 1 - - - - - - -
Book Value Per Share 2 - 13.00 12.20 - 11.80 13.00 13.10
Cash Flow per Share - 2.120 1.160 - - - -
Capex 1 - 29.8 36.4 - 48.6 47.2 50.4
Capex / Sales - 6.52% 7.63% - 9.34% 8.39% 8.34%
Announcement Date 8/16/21 2/22/22 2/21/23 2/22/24 - - -
1CHF in Million2CHF
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
15.22 CHF
Average target price
30 CHF
Spread / Average Target
+97.11%
Consensus